China Pharma Holdings, Inc. CPHI · SEC Filings

website

215

China Pharma Holdings, Inc. (CPHI) specializes in the development, manufacturing, and marketing of b...

Price0.565

Market Cap24.52 M

Float30.35 M

CountryCN

SectorHealthcare

ExchangeAMEX

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Apr 1, 2026

NT 10-K

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Apr 1, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jul 23, 2026

424B5

ATM | Offering amount: $600,000 | Amount sold to date: $0 | Float: 10,039,497

Dec 13, 2024

424B5

SHELF OFFERING | Share price: $0.43 | Offering amount: $5,000,000.00

Dec 16, 2021

424B3

6,450 ,000 Shares of Common Stock

Oct 1, 2009

424B3

6,450,000 Shares of Common Stock

Sep 28, 2009

424B3

6,450 ,000 Shares of Common Stock

Jun 30, 2009

Registrations

TYPE

HEADLINE

FILED AT

S-3/A

SHELF | Offering amount: $50,000,000.00 EFFECTIVE

Feb 6, 2024

S-3

SHELF | Offering amount: $50,000,000.00 EFFECTIVE

Jan 12, 2024

S-8

Registration

Oct 24, 2022

Form D - Notice of Exempt Offering of Securities - Item 06b

Nov 29, 2021

S-3

Common Stock- EFFECTIVE

Jan 8, 2021

S-8

Registration

Dec 21, 2020

Proxies

TYPE

HEADLINE

FILED AT

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Oct 30, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Nov 14, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Nov 4, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Nov 12, 2024

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Nov 1, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Nov 7, 2023

Ownerships

TYPE

HEADLINE

FILED AT

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Feb 6, 2024

SC 13G

Liu Tao (Chengdu) (Filed by)

Jan 26, 2024

Liu Tao (Chengdu) (Reporting)

Jan 26, 2024

S-3

Form S-3 - Registration statement under Securities Act of 1933

Jan 12, 2024

SC 13G/A

Streeterville Capital LLC (Filed by)

Jan 12, 2024

Li Zhilin (Reporting)

Oct 19, 2023

Other

TYPE

HEADLINE

FILED AT